Crescent Biopharma (CBIO) Return on Sales Growth (1y) (2014 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 4.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.00 |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 484.00 |
| Sep 30, 2022 | -100.00 |
| Jun 30, 2022 | 101,226.00 |
| Dec 31, 2021 | -893.00 |
| Sep 30, 2021 | -187.00 |
| Jun 30, 2021 | -101,398.00 |
| Mar 31, 2021 | -13.00 |
| Sep 30, 2017 | -1,344.00 |
| Sep 30, 2016 | -224.00 |
| Dec 31, 2015 | -250.00 |
| Sep 30, 2015 | -202.00 |
| Jun 30, 2015 | 0.00 |
| Mar 31, 2015 | 86.00 |
| Dec 31, 2014 | 49.00 |
| Sep 30, 2014 | 70.00 |
| Jun 30, 2014 | 64.00 |
| Mar 31, 2014 | -87.00 |